#Pfizer has claimed its first #regulatoryapproval for a #GLP1 agonist in #obesity, getting a green light in #China for ecnoglutide, a once-weekly #injectable drug licensed from Hangzhou-based #SciwindBiosciences in February.

buff.ly/wJeVK7h

EU approves Otsuka's long-acting HAE drug Dawnzera An EMA nod for Otsuka's Dawnzera offers EU patients with HAE a drug that can be self-administered by patients with up to eight weeks between doses.

#hereditaryangioedema #Otsuka #Ionis #Dawnzera #regulatoryapproval #Rarediseases #pharmanews #HAEdrug #Dawnzera #antisenseoligonucleotidebasedplasmaprekallikreininhibitor #PKKinhibitor #plasmaprekallikreininhibitor #PKK #EMA #HAEpatients #clinicaltrials #RNAtargetedtherapy
zurl.co/Zw7sM

🔗 Read more: bit.ly/ONCOnews15J-01

#ONCOnews #OncoAlert #OncEd #NSCLC #RegulatoryApproval #CancerResearch #Oncology #SFDA

Netflix leaders Ted Sarandos and Greg Peters sent a memo to staff on Monday. They confirmed the $82.7 billion purchase of Warner Bros and HBO Max. #Hollywoodindustry #netflix #RegulatoryApproval #streamingmergers #WarnerBros

Netflix leaders Ted Sarandos and Greg Peters sent a memo to staff on Monday. They confirmed the $82.7 billion purchase of Warner Bros and HBO Max. #Hollywoodindustry #netflix #RegulatoryApproval #streamingmergers #WarnerBros

Netflix leaders Ted Sarandos and Greg Peters sent a memo to staff on Monday. They confirmed the $82.7 billion purchase of Warner Bros and HBO Max. #Hollywoodindustry #netflix #RegulatoryApproval #streamingmergers #WarnerBros

Prediction Markets Kalshi, Polymarket Hit Record November: $11B Valuation, US Approval The booming prediction market sector, propelled by record growth from platforms Kalshi and Polymarket, is now confronting a critical regulatory challenge that

Prediction Markets Kalshi, Polymarket Hit Record November: $11B Valuation, US Approval

#CFTC #Kalshi #Polymarket #PredictionMarkets #Regulatoryapproval

Utah PSC hears extensions for Kennecott power purchase agreements; Division recommends approval Rocky Mountain Power asked the Utah Public Service Commission to approve sixth amendments extending two power purchase agreements with Kennecott Utah Copper LLC through 2026; the Division of Public Utilities reviewed the filings and recommended approval, and both company and division exhibits were admitted into evidence.

The Utah Public Service Commission is considering pivotal extensions for power agreements between Rocky Mountain Power and Kennecott Utah Copper, which could shape the future of energy in the region.

Click to read more!

#UT #CitizenPortal #EnergyPolicy #SustainableEnergy #RegulatoryApproval

Waymo gets regulatory approval to expand across Bay Area and Southern California Waymo continues to expand its reach, with the robotaxi company posting Friday that it’s now “officially authorized to drive fully autonomously across more of the Golden State.”

Waymo gets regulatory approval to expand across Bay Area and Southern California #Technology #Business #TransportationTech #Waymo #RegulatoryApproval #AutonomousVehicles

TALEN Energy Secures Regulatory Approval for Planned Acquisitions of Freedom Energy Holdings and Guernsey Power Plant TALEN Energy has secured regulatory approval from the Federal Energy Regulatory Commission (FERC) to proceed with its planned acquisitions of Freedom Energy Holdings and Guernsey Power Plant, two major players in the natural gas-powered peaking plants sector in the Northeast region and a coal-fired power generation facility in Ohio, respectively.

TALEN Energy Secures Regulatory Approval for Planned Acquisitions of Freedom Energy Holdings and Guernsey Power Plant #PJM #TalenEnergy #RegulatoryApproval #MergersAndAcquisitions #PowerGeneration #Ferc

Benfica Greenlit: First Portuguese Club to Own Sports Radio Portugal's media regulator has cleared the way for Sport Lisboa e Benfica to become the first football club in the country to fully own and operate a

Benfica Greenlit: First Portuguese Club to Own Sports Radio

#Benfica #BenficaFM #erc #Regulatoryapproval #sportsradio

FDA clears Novartis' oral drug for chronic hives Novartis has claimed a first-in-class approval in the US for its oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria.

#Novartis has claimed a first-in-class #regulatoryapproval in the US for oral #BTKinhibitor remibrutinib as a second-line treatment for #chronicspontaneousurticaria (CSU), also known as chronic #hives.

Regional Power Grid Expansion Sparks Debate Over New Transmission Lines A proposed expansion of the regional power grid, known as the B3800 series, has sparked a heated debate among residents, politicians, and utility companies in the Mid-Atlantic region. The multi-billion-dollar project, which involves several interconnected upgrades to existing transmission lines, aims to increase grid reliability and capacity to meet growing electricity demands. However, concerns over property seizures, potential energy job losses, and environmental impacts have led to widespread opposition, with thousands of letters of protest submitted to regulatory agencies, highlighting the complexities and challenges associated with modern grid planning.

Regional Power Grid Expansion Sparks Debate Over New Transmission Lines #PJM #EnergyEfficiency #TransmissionLines #ElectricityGrid #RegulatoryApproval #RenewableEnergy

Apple Watch Hypertension Notifications Gain FDA Approval, Launching Soon Your Apple Watch is about to become an even smarter health guardian. A brand-new feature to spot high blood pressure signs just got official OK from the FDA.

Apple Watch Hypertension Notifications Gain FDA Approval, Launching Soon

#applewatch #hypertension #Regulatoryapproval

Constellation Applauds New York's Nuclear Energy Support Constellation Applauds New York’s Nuclear Energy Support June 23, 2025 Constellation has released a statement praising Governor Hochul’s recent dedication to nuclear power within New York State. The company views this commitment as crucial for achieving clean energy goals and maintaining a reliable power grid. They highlighted the importance of nuclear facilities in providing consistent, carbon-free electricity. Partnership Expands Home Charging Solutions June 20, 2025 To enhance customer access to electric vehicle charging infrastructure, Constellation has announced a collaboration with Treehouse. This partnership establishes a more extensive and robust network for home charging installation services, aiming to simplify the process for EV owners. The combined efforts will broaden availability and improve the overall customer experience. New York Regulators Approve Calpine Acquisition June 16, 2025 The New York Public Service Commission has formally approved Constellation's agreement to acquire Calpine. This milestone allows Constellation to proceed with integrating Calpine's assets and expertise, strengthening its position in the energy market. The decision follows a thorough review process. Executive Testifies on Energy Strategy June 12, 2025 Kathleen Barrón, Chief Strategy & Growth Officer at Constellation, recently testified before a House Subcommittee on Energy. Her testimony focused on the company’s strategic approach to growth and its role in shaping the future of energy. The session addressed key industry challenges and opportunities. Texas Regulatory Approval Granted for Calpine Deal June 05, 2025 Constellation’s acquisition of Calpine has received approval from Texas regulatory authorities. This clearance marks another significant step toward finalizing the deal, demonstrating progress in satisfying all necessary regulatory approvals.

Constellation Applauds New York's Nuclear Energy Support #PJM #NuclearPower #EnergyGoals #CarbonFree #ElectricVehicles #RegulatoryApproval

’Deep pockets’ could help Abu Dhabi win regulatory approval for Santos bid, analysts say By Scott Murdoch and Christine Chen SYDNEY (Reuters) -Abu Dhabi National Oil Company, preparing an $18.7 billion bid for Santos, is likely to face close scrutiny from Australian regulators worried about local gas supply, but could win them over with pledges to speed up new projects, analysts say. Santos shares closed at A$7.73 on Tuesday, well below the $5.76 (A$8.89) per share proposed takeover offer for Australia’s second largest gas producer announced on Monday, which analysts said indicated investors believe the deal will face trouble with regulators. "It’s not going to be smooth sailing yet," said Jamie Hannah, Deputy Head of Investments and Capital Markets at VanEck Australia, which owns shares in Santos. However, he added that the offer price "is very attractive and it’s straight cash". The bid, which would be the largest ever all-cash takeover in Australia, according to FactSet data, has landed at a time when Australia’s Labor government is debating how to deal with a looming gas shortage on the country’s east coast from 2027. "We would expect the Foreign Investment Review Board (FIRB) to focus on Santos’s key gas infrastructure as it relates to domestic gas supply," said Jarden analyst Nik Burns. Santos’ market share in eastern Australia is around 5%, with most of its gas output on that side of the country going to its Gladstone LNG export plant, analysts said. In Western Australia, where it runs two domestic gas plants and has a stake in a third one, it has a 24% market share. The infrastructure assets were not major income-generating assets, so would be very hard to spin off to satisfy any regulatory concerns, said Hannah. "This infrastructure is important for domestic gas supply in both markets. The government needs to decide if they are happy for this to sit in the hands of a foreign government," said MST Marquee analyst Saul Kavonic. ADNOC BRINGS CAPITAL TO THE TABLE On the positive side, Santos holds undeveloped resources, including the Narrabri project and Beetaloo shale gas, that could help fill the expected gas supply gap on the east coast. The bidding consortium, headed by ADNOC’s investment arm XRG, could argue it would develop those projects faster than Santos could under its plans to boost capital returns to shareholders, and reduce the risk of an east coast gas shortage. "XRG might point to regulators that its larger balance sheet and funding capacity provides an opportunity to accelerate Santos’ undeveloped growth assets," UBS analyst Tom Allen said in a research note. Romano Sala Tenna, portfolio manager at Katana Asset Management, which owns Santos shares, said the market was being too pessimistic about regulatory hurdles. "A large sovereign wealth fund effectively coming in with deep pockets" could pour money into Santos’ undeveloped assets, he said. "So I think that is a card that will be appealing to the Australian government." XRG said on Monday that if the deal goes ahead, the consortium aims to build on Santos’ legacy as a reliable energy producer "unlocking additional gas supply" and intends to "work closely with the existing management team to accelerate growth". Another factor that could work in favour of the ADNOC-led consortium, which includes the Abu Dhabi Development Holding Company (ADQ) and U.S.-based private equity firm Carlyle, is a trade deal Australia signed last year with the United Arab Emirates, analysts said. Australian Treasurer Jim Chalmers, who has the final say on approving major foreign transactions, said he would listen to the advice of the Foreign Investment Review Board on the deal. Santos Chief Executive Kevin Gallagher declined to comment on the deal and regulatory concerns on the sidelines of a gas conference in Malaysia on Tuesday, other than to say he would "let the process take its course". Should you invest $2,000 in STO right now? Before you buy stock in STO, consider this: ProPicks AI are 6 easy-to-follow model portfolios created by Investing.com for building wealth by identifying winning stocks and letting them run. Over 150,000 paying members trust ProPicks to find new stocks to buy – driven by AI. The ProPicks AI algorithm has just identified the best stocks for investors to buy now. The stocks that made the cut could produce enormous returns in the coming years. Is STO one of them?

Click Subscribe #AbuDhabi #Santos #OilAndGas #Investment #RegulatoryApproval

Bunge receives China regulatory approval for Viterra deal CHICAGO (Reuters) -Global agribusiness Bunge (NYSE:BG) Global SA has received regulatory approval from China for its acquisition of grain handler Viterra and expects to close the $34 billion deal "on or around July 2," the company said in a statement on Friday. The deal, first announced in 2023, will create a global crop trading and processing giant closer in scale to chief rivals Archer-Daniels-Midland and Cargill. Approval from China was the final regulatory approval Bunge needed to finalize the deal after gaining approvals from regulators in Canada, the European Union and other markets. "Achieving this regulatory milestone is a significant step forward and clears the way for closing of the transaction. This approval underscores the strategic rationale behind bringing Bunge and Viterra together to create a premier global agribusiness company," CEO Greg Heckman said in an emailed statement. Bunge shares were up 6.1% at midday on Friday. ADM: A Bull or Bear Market Play? Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks – 6 model portfolios fueled by AI stock picks with a stellar performance this year.. In 2024 alone, ProPicks' AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if ADM is on your watchlist, it could be very wise to know whether or not it made the ProPicks lists.

Click Subscribe #Bunge #Viterra #China #RegulatoryApproval #StockMarket

From market access to real-world patient access: Closing the gap for biosimilar medicines

#biosimilars #marketaccess #pharmaceuticalspending #healthcaresystemsustainability #regulatoryapproval #reimbursement #patientaccess #regulatoryapprovals #comparativeefficacytrials #MHRA #intellectualproperty #regulatorypathways #valuebasedhealthcare
pharmaphorum.com/deep-dive/ma...

Pending regulatory approval, this deal might take up to 9 months for FTC's final approval. 20/200 #RegulatoryApproval https://fefd.link/hAkL9

J&J's 'Swiss army knife' drug gets first FDA approval Johnson & Johnson has its first regulatory approval for FcRn blocker Imaavy, getting a green light in the US for generalised myasthenia gravis (gMG).

NEWS: #JohnsonandJohnson has its first #regulatoryapproval for FcRn blocker Imaavy, getting a green light in the US for the would-be blockbuster as a treatment for #generalisedmyastheniagravis.

pharmaphorum.com/news/jjs-swi...

Tesla pauses smart driving feature in China pending regulatory approval Investing.com -- Tesla (NASDAQ:TSLA) announced on Monday that it plans to introduce its smart driving-assistance feature in China, following the completion of regulatory approval. This comes after the company faced complaints for temporarily pausing a limited-time free trial of its Full Self-Driving (FSD) service. Tesla’s customer support, in a social media post on Weibo (NASDAQ:WB), stated that all parties are actively advancing the process and will push the feature as soon as it is ready. The company is also eagerly anticipating the launch, urging customers to wait patiently. This message was posted as a comment under Tesla vice president Grace Tao’s Weibo feed. Last Monday, Tesla had said that it would initiate the free trial of its FSD service in China from March 17 to April 16. The FSD service is a suite of driving-assistance technologies developed with generative artificial intelligence to handle more complex traffic conditions. The company’s goal for this year is to fully roll out FSD, and it is collaborating with Chinese tech giant Baidu (NASDAQ:BIDU) to enhance the system’s performance. Tesla has previously offered such trials in the United States. In the U.S., the FSD system does not necessitate navigation maps to be accurate or current, as local training of the AI helps improve the technology’s driving capabilities. However, in China, Tesla has been unable to train the system with data from its 2 million electric vehicles due to the country’s data laws. In late February, China’s industry ministry established new rules requiring autonomous driving-related over-the-air software upgrades to receive regulatory approval. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Click Subscribe #Tesla #SmartDriving #China #RegulatoryApproval #FullSelfDriving

Safran Pursues AI Advancement with Talks to Acquire Preligens for €220M Preligens enhances military situational awareness with AI analytics for aerospace and defense, analyzing imagery, video, and acoustic signals.

Safran Pursues AI Advancement with Talks to Acquire Preligens for €220M
www.defensemirror.com/news/37116/S...
#Safran #Preligens #AI #Aerospace #Defense #Acquisition #AIAnalytics #SituationalAwareness #DecisionMaking #MilitaryTechnology #Manufacturing4.0 #InternationalExpansion #RegulatoryApproval

एलन मस्क का भारत दौरा स्थगित; भारतीय बाज़ार में प्रवेश करने की योजना में देरी Elon Musk's visit to India postponed. Tesla's entry into Indian market delayed. Regulatory approval for Starlink awaited.

एलन मस्क का भारत दौरा स्थगित; भारतीय बाज़ार में प्रवेश करने की योजना में देरी

www.newsfeedindia.in/2024/04/Elon...

#ElonMusk #Tesla #IndiaVisit #MarketEntry #Starlink #RegulatoryApproval #BusinessNews #PMModi